National Securities
- Average 12 Month ROI on "Buy" Recommendations
- 87.281%
- Based on
- 76 research note(s)
- MarketBeat Brokerage Ranking
- 5 of 5 stars
Recent Recommendations from National Securities
- JOYY Inc. (NASDAQ: YY) had its "buy" rating re-affirmed by analysts at National Securities. They now have a $132.00 price target on the stock. (6/18/2021)
- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) is now covered by analysts at National Securities. They set a "buy" rating on the stock. (2/9/2021)
- Genprex, Inc. (NASDAQ: GNPX) is now covered by analysts at National Securities. They set a "buy" rating and a $280.00 price target on the stock. (1/26/2021)
- iQIYI, Inc. (NASDAQ: IQ) had its "buy" rating re-affirmed by analysts at National Securities. They now have a $23.20 price target on the stock. (12/24/2020)
- iHuman Inc. (NYSE: IH) is now covered by analysts at National Securities. They set a "buy" rating and a $26.10 price target on the stock. (12/24/2020)
